Publication:
First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis

Simple item page
dc.contributor.authorGÜMÜŞ, MAHMUT
dc.contributor.authorTurk, H.
dc.contributor.authorBilir, C.
dc.contributor.authorSendur, M.
dc.contributor.authorKarabulut, B.
dc.contributor.authorArtac, M.
dc.contributor.authorCicin, I.
dc.contributor.authorGeredeli, C.
dc.contributor.authorAlacacioglu, A.
dc.contributor.authorKefeli, U.
dc.contributor.authorHarputluoglu, H.
dc.contributor.authorBozkurt, O.
dc.contributor.authorCubukcu, E.
dc.contributor.authorTural, D.
dc.contributor.authorSakin, A.
dc.contributor.authorCil, T.
dc.contributor.authorDane, F.
dc.contributor.authorCevik, D.
dc.contributor.authorArslan, C.
dc.contributor.authorKaradurmus, N.
dc.contributor.authorYALÇIN, SIDDIKA SONGÜL
dc.date.accessioned2022-08-20T17:09:38Z
dc.date.available2022-08-20T17:09:38Z
dc.date.issued2022-06-01T00:00:00Z
dc.identifier.citationIsikdogan A., Turk H., Bilir C., Sendur M., Karabulut B., Artac M., Cicin I., Geredeli C., Alacacioglu A., Kefeli U., et al., -First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis-, ANNALS OF ONCOLOGY, cilt.33, 2022
dc.identifier.doi10.1016/j.annonc.2022.04.180
dc.identifier.urihttp://hdl.handle.net/20.500.12645/30868
dc.identifier.wosWOS:000823826500103
dc.titleFirst-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis
dc.typeArticle
dspace.entity.typePublication
local.avesis.id3e87dfd9-3708-43ac-a1b8-ef20721245c7
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files
Collections
Yayınlar - Eserler